Maze Therapeutics, Inc.
MAZE
$9.07
-$0.25-2.68%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
4/5/2025
-
MarketBeat
4/4/2025
-
MarketBeat
4/1/2025
-
MarketBeat
3/31/2025
-
Ticker Report
3/31/2025
-
GuruFocus
3/31/2025
-
The Fly
3/31/2025
-
Globe Newswire
3/26/2025
-
SeekingAlpha
3/19/2025
-
MarketBeat
3/19/2025
-
ETF Channel
3/18/2025
-
MarketBeat
3/11/2025
-
MarketBeat
3/5/2025
-
MarketBeat
3/5/2025
-
MarketBeat
2/27/2025
-
Ticker Report
2/27/2025
-
MarketBeat
2/26/2025
-
MarketBeat
2/25/2025
-
MarketBeat
2/25/2025
-
MarketBeat
2/25/2025
-
MarketBeat
2/25/2025
-
Ticker Report
2/25/2025
-
MarketBeat
2/25/2025
-
TipRanks Financial Blog
2/25/2025
-
The Fly
2/25/2025
-
The Fly
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, March 31, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of Aug 11 and 15 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
--
90-Day Total Return
--
Year to Date Total Return
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 850 5070
Address
171 Oyster Point Blvd
South San Francisco, CA 94080
South San Francisco, CA 94080
Country
Year Founded
Business Description
Sector
Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of renal, cardiovascular, related metabolic diseases, and...
more
